Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000215545 | SCV000279015 | uncertain significance | not provided | 2017-05-26 | criteria provided, single submitter | clinical testing | To our knowledge, the Q803H missense substitution in the LPIN2 gene has neither been published as a mutation, nor reported as a benign polymorphism. Q803H represents a non-conservative amino acid substitution as a neutral, polar Glutamine amino acid is replaced with a positively-charged Histidine amino acid. In addition, this substitution occurs at a position in the LPIN2 protein that is well-conserved in mammalian species. However, as the clinical information regarding LPIN2 variants is limited, it is unclear whether Q803H is a disease-associated mutation or a rare, benign polymorphism. |
Labcorp Genetics |
RCV000560055 | SCV000645171 | uncertain significance | Majeed syndrome | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine with histidine at codon 803 of the LPIN2 protein (p.Gln803His). The glutamine residue is moderately conserved and there is a small physicochemical difference between glutamine and histidine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with LPIN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 234342). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |